Saturday, February 22nd, 2025

Genting Singapore: Bright Prospects Ahead with Recovery in Tourism and Strategic Enhancements

Date of Report: 3 October 2024
Broker: UOB Kay Hian


Positive Outlook for 2H24

Genting Singapore (GENS) has a bright outlook for the second half of 2024, supported by multiple catalysts. The company is expected to benefit from an accelerated recovery in foreign visitor arrivals and increased flight frequencies.


Major Entertainment Events

The upcoming major entertainment events, including the Formula 1 Grand Prix, are anticipated to drive higher footfall to Resorts World Sentosa (RWS). Additionally, the sustained trend of increased average spending at the integrated resort, particularly in non-gaming segments, is expected to contribute positively to the company’s performance.


New Hotel Launch and Increased Capacity

Genting Singapore’s recent launch of Hotel Ora is projected to enhance key inventories by approximately 30% year-on-year. This addition is expected to further attract visitors and increase overall revenue streams for the company.


Strong Digital Marketing Efforts

The company has intensified its digital marketing initiatives, which are likely to lead to higher visitor footfall and spending at RWS. These efforts are part of a broader strategy to capitalize on the recovering tourism market.


Financial Position and Target Price

UOB Kay Hian maintains a “BUY” rating for Genting Singapore, with a target price of S$1.25. This valuation reflects the company’s robust financial position and the potential for earnings growth as the tourism sector continues to recover.


Key Catalysts for Growth

Key events that could enhance Genting Singapore’s share price include:

  • A continued recovery in patronage from Chinese tourists as flight frequencies increase.
  • Effective management of capital resources following the withdrawal from Japan’s Integrated Resort pursuit.
  • A commendable yield forecast of 4.5% for 2024, attracting investor interest.

GSH Corp Stock Surges: Technical Buy Signal Emerges with Bullish Reversal and Increased Momentum

Comprehensive Company Analysis: CGS Trendspotter Report (January 20, 2025) Comprehensive Company Analysis: CGS Trendspotter Report (January 20, 2025) Broker: CGS Trendspotter Date of Report: January 20, 2025 Introduction The latest CGS Trendspotter report unveils...

Alpha IVF: Expanding Internationally with Strong Growth Prospects

Date of Report: 22 October 2024Broker: UOB Kay Hian Company Overview Alpha IVF is a renowned network of fertility centers across the ASEAN region, managed by leading doctors and embryologists known for their significant...

XPeng Stock Analysis: Bullish Momentum and Technical Buy Signal for Chinese EV Maker

Trendspotter: In-Depth Analysis of XPeng Inc, Cromwell European REIT, Elite UK REIT, and Netlink NBN Trust Trendspotter: In-Depth Analysis of XPeng Inc, Cromwell European REIT, Elite UK REIT, and Netlink NBN Trust Broker: CGS...